Suchergebnisse - "Bekaii-Saab, T"

PubPharm (39)

1

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

enthalten in: ESMO open | 2023

von Ducreux, M. | Abou-Alfa, G. | Bekaii-Saab, T. | +28

2

Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers : A Multi-center Prospective Study

enthalten in: Digestive diseases and sciences | 2022

von Uson, P. | Kunze, K. | Golafshar, M. | +13

3

Practical considerations in screening for genetic alterations in cholangiocarcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Bekaii-Saab, T. | Bridgewater, J. | Normanno, N.

4

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer : a report from the COVID-19 and Cancer Consortium

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Grivas, P. | Khaki, A. | Wise-Draper, T. | +98

5

Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells

enthalten in: Oncogene | 2016

von Chu, P. | Yang, M. | Kulp, S. | +10

6

Reconsidering the benefit of intermittent versus continuous treatment in the maintenance treatment setting of metastatic colorectal cancer

enthalten in: Cancer treatment reviews | 2016

von Sunakawa, Y. | Bekaii-Saab, T. | Stintzing, S.

7

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC) : a single-institution experience

enthalten in: Medical oncology (Northwood, London, England) | 2016

von Bupathi, M. | Ahn, D. | Wu, C. | +5

8

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience

enthalten in: Medical oncology | 2016

von Bupathi, M. | Ahn, D. | Wu, C. | +5

9

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience

enthalten in: Medical oncology | 2016

von Bupathi, M. | Ahn, D. | Wu, C. | +5

10

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Bridgewater, J. | Lopes, A. | Wasan, H. | +12